Candesartan Effect in Second Stage Arterial Hypertension

Clinical trial NCT00621153 · COMPLETED

Trial details

NCT number: NCT00621153
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Stage II Hypertension

Start date: 2008-02-01
Primary completion: 2009-03-01
Enrollment: 214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.